Abstract
Technological advances in fields such as computer modelling and simulation are playing a fundamental role, during the COVID-19 pandemic, that has been afflicting us for 2 years now. These methodologies may help in the development, assessment and monitoring for better prevention, diagnosis, treatment and generation of specific therapeutic strategies. In this perspective, in silico platforms are emerging thanks to their ability to predict the efficacy and safety of new therapies and vaccines. Here, our integrated bioinformatics pipeline for evaluating the elicited response of human immune system against every pathogen is applied to predict the cross-reactive immunity induced by pre-existing vaccinations against SARS-CoV-2 UK variants.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
